Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

324 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Resting metabolic rate, fat-free mass and catecholamine excretion during weight loss in female obese patients.
Menozzi R, Bondi M, Baldini A, Venneri MG, Velardo A, Del Rio G. Menozzi R, et al. Br J Nutr. 2000 Oct;84(4):515-20. Br J Nutr. 2000. PMID: 11103222
Ninety-three obese female subjects consumed a low-energy diet (LED) (2930 kJ/d (700 kcal/d)) for a 3-week period. At the beginning and at the end of the study, 24 h urinary excretion of catecholamines, FFM and RMR were measured. ...Urinary noradrenalin excretion exp …
Ninety-three obese female subjects consumed a low-energy diet (LED) (2930 kJ/d (700 kcal/d)) for a 3-week period. At the begin …
Chronobiology of catecholamine excretion in normal and diabetic men.
Del Rio G, Carani C, Baldini A, Marrama P, Della Casa L. Del Rio G, et al. J Endocrinol Invest. 1990 Jul-Aug;13(7):575-80. doi: 10.1007/BF03348628. J Endocrinol Invest. 1990. PMID: 2229930
The dopamine excretion was correlated with noradrenaline excretion in normal subjects but did not show a definite circadian rhythm. ...The dopamine excretion does not show circadian variations and this probably reflects the absence of a single controlling oscillator …
The dopamine excretion was correlated with noradrenaline excretion in normal subjects but did not show a definite circadian rhythm. . …
Adrenomedullary hyperactivity in type I diabetic patients before and during continuous subcutaneous insulin treatment.
Del Rio G, Baldini A, Carani C, Della Casa L. Del Rio G, et al. J Clin Endocrinol Metab. 1989 Mar;68(3):555-9. doi: 10.1210/jcem-68-3-555. J Clin Endocrinol Metab. 1989. PMID: 2645311
These data demonstrate hyperactivity of the adrenal medulla in type I diabetic patients, which is only partially reversed by a short period of glycemic control....
These data demonstrate hyperactivity of the adrenal medulla in type I diabetic patients, which is only partially reversed by a short …
Risk for cardiovascular events in an Italian population of patients with type 2 diabetes.
Pellegrini E, Maurantonio M, Giannico IM, Simonini MS, Ganazzi D, Carulli L, D'Amico R, Baldini A, Loria P, Bertolotti M, Carulli N. Pellegrini E, et al. Nutr Metab Cardiovasc Dis. 2011 Nov;21(11):885-92. doi: 10.1016/j.numecd.2010.02.022. Epub 2010 Jul 31. Nutr Metab Cardiovasc Dis. 2011. PMID: 20674312
A stratification was obtained in subgroups at different cardiovascular risk, allowing comparison between the algorithms. A total of 1532 patients were eligible; women presented a worse cardiovascular risk profile. ...Functions designed for a specific p
A stratification was obtained in subgroups at different cardiovascular risk, allowing comparison between the algorithms. A tot
Combined treatment with growth hormone and luteinizing hormone releasing hormone-analogue (LHRHa) of pubertal children with familial short stature.
Volta C, Bernasconi S, Tondi P, Salvioli V, Ghizzoni L, Baldini A, Alberini A, Carani C. Volta C, et al. J Endocrinol Invest. 1993 Nov;16(10):763-7. doi: 10.1007/BF03348921. J Endocrinol Invest. 1993. PMID: 8144848 Clinical Trial.
We evaluated the 12 month growth of 18 pubertal children with familial short stature randomly assigned to clinical follow-up (group A), GH treatment alone (group B) and GH+LHRH analogue (LHRHa) treatment (group C). Height velocity increased significantly compared to baseli …
We evaluated the 12 month growth of 18 pubertal children with familial short stature randomly assigned to clinical follow-up (group A
Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: A multicenter study.
Papi G, Corsello SM, Cioni K, Pizzini AM, Corrado S, Carapezzi C, Fadda G, Baldini A, Carani C, Pontecorvi A, Roti E. Papi G, et al. J Endocrinol Invest. 2006 May;29(5):427-37. doi: 10.1007/BF03344126. J Endocrinol Invest. 2006. PMID: 16794366 Clinical Trial.
On the contrary, a correct cytological diagnosis was obtained in only one out of five patients with <10 mm MTC nodules (microMTC); in one patient with histologically proved microMTC, FNAC even demonstrated a benign lesion. ...Although CT is not a specific …
On the contrary, a correct cytological diagnosis was obtained in only one out of five patients with <10 mm MTC nodules (microMTC); …
Effects of cyproterone acetate, LHRH agonist and ovarian surgery in McCune-Albright syndrome with precocious puberty and galactorrhea.
Carani C, Pacchioni C, Baldini A, Zini D. Carani C, et al. J Endocrinol Invest. 1988 Jun;11(6):419-23. doi: 10.1007/BF03349073. J Endocrinol Invest. 1988. PMID: 2974851
The effects of treatment with antiandrogen drug, cyproterone acetate, and of a LHRH agonist, buserelin (less than D-Ser[TBU(8)6-des-gly NH2.10 greater than LHRH ethylamide), were studied. ...It is likely that in this case of McCune-Albright syndrome precocious puberty was …
The effects of treatment with antiandrogen drug, cyproterone acetate, and of a LHRH agonist, buserelin (less than D-Ser[TBU(8)6-des-g …
Changes in the bioactivity to immunoreactivity ratio of circulating luteinizing hormone in impotent men treated with testosterone undecanoate.
Carani C, Celani MF, Zini D, Baldini A, Della Casa L, Marrama P. Carani C, et al. Acta Endocrinol (Copenh). 1989 Mar;120(3):284-8. doi: 10.1530/acta.0.1200284. Acta Endocrinol (Copenh). 1989. PMID: 2648724 Clinical Trial.
Bioactive LH was measured by a sensitive and specific in vitro bioassay based on testosterone production by mechanically dispersed mouse Leydig cell preparations. Immunoreactive LH and testosterone were determined by a double-antibody RIA technique. The results were …
Bioactive LH was measured by a sensitive and specific in vitro bioassay based on testosterone production by mechanically dispersed mo …
Effects of androgen treatment in impotent men with normal and low levels of free testosterone.
Carani C, Zini D, Baldini A, Della Casa L, Ghizzani A, Marrama P. Carani C, et al. Arch Sex Behav. 1990 Jun;19(3):223-34. doi: 10.1007/BF01541548. Arch Sex Behav. 1990. PMID: 2193636 Clinical Trial.
The results of our study suggest the presence of a minimum serum fT threshold, lying near the lower normal range, which determines the male sexual function. Moreover, serum fT levels were a more sensitive index than tT for identifying impotent men who can be success …
The results of our study suggest the presence of a minimum serum fT threshold, lying near the lower normal range, which determines th …
Sexual behavior of men with isolated hypogonadotropic hypogonadism or prepubertal anterior panhypopituitarism.
Zini D, Carani C, Baldini A, Ghizzani A, Marrama P. Zini D, et al. Horm Behav. 1990 Jun;24(2):174-85. doi: 10.1016/0018-506x(90)90003-g. Horm Behav. 1990. PMID: 2365300
During and after withdrawal of Gn administration, men with isolated deficit of Gn retained sexual activity and nocturnal penile tumescence, although they were partially compromised compared with a control group; on the other hand, panhypopituitarics reported compromised se …
During and after withdrawal of Gn administration, men with isolated deficit of Gn retained sexual activity and nocturnal penile tumescence, …
324 results
Jump to page
Feedback